Q2 2016 Holdings
Filed 2016-08-15 | 5 holdings | $584.9K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Seres Therapeutics Inc(MCRB1EUR) | COM | 81750R102 | $368.4K | 12,682,876 | 63.0% |
| Editas Medicine Inc(EDIT) | COM | 28106W103 | $120.9K | 4,955,316 | 20.7% |
| Syros Pharmaceuticals Inc | COM | 87184Q107 | $87.2K | 4,806,656 | 14.9% |
| T2 Biosystems Inc | COM | 89853L104 | $5.9K | 741,755 | 1.0% |
| Eleven Biotherapeutics Inc | COM | 286221106 | $2.5K | 1,466,417 | 0.4% |